Marek Pruszyński

Deciphering O -glycoprotease substrate preferences with O-Pair Search

Design of a mucin-selective protease for targeted degradation of cancer-associated mucins

Immunogenicity Risk Profile of Nanobodies

Stability of 47Sc-complexes with acyclic polyamino-polycarboxylate ligands

Building better monoclonal antibody-based therapeutics

Challenges and opportunities for non-antibody scaffold drugs

Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS

Imaging of Protein Synthesis: In Vitro and In Vivo Evaluation of 44Sc-DOTA-Puromycin

Measuring the multifaceted roles of mucin-domain glycoproteins in cancer

Aptamers as targeted therapeutics: current potential and challenges

Assessment of radionuclidic impurities in cyclotron produced 99mTc

Evaluation of excitation functions of 100Mo(p,d+pn)99Mo and 100Mo (p,2n)99mTc reactions: Estimation of long-lived Tc-impurity and its implication on the specific activity of cyclotron-produced 99mTc

Matching chelators to radiometals for radiopharmaceuticals

THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience

Cyclotron production of 99mTc: Experimental measurement of the 100Mo(p,x)99Mo, 99mTc and 99gTc excitation functions from 8 to 18 MeV

Development of therapeutic antibodies for the treatment of diseases

In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism

Luminescent Chemodosimeters for Bioimaging

Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals

Nanotechnology for Multimodal Synergistic Cancer Therapy

Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer

Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies

Phosphorescent Iridium(III) Complex with an N^∧O Ligand as a Hg²⁺-Selective Chemodosimeter and Logic Gate

Tc-99m production with ultrashort intense laser pulses

Macrocyclic complexes of scandium radionuclides as precursors for diagnostic and therapeutic radiopharmaceuticals

Evaluation ofMo99andTc99mProductions Based on a High-Performance Cyclotron

Radiolabeling Strategies for Tumor-Targeting Proteinaceous Drugs

Radiometals for Combined Imaging and Therapy

Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody

131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment

Astatine-211: Production and Availability

Improved Tumor Targeting of Anti-HER2 Nanobody Through N-Succinimidyl 4-Guanidinomethyl-3-Iodobenzoate Radiolabeling

New measurement of excitation functions for (p,x) reactions on natMo with special regard to the formation of 95mTc, 96m+gTc, 99mTc and 99Mo

Radiolabeling of DOTATOC with the long-lived positron emitter 44Sc

Post-elution processing of 44Ti/44Sc generator-derived 44Sc for clinical application

Preparation of Rh[16aneS₄-diol]²¹¹At and Ir[16aneS₄-diol]²¹¹At Complexes as Potential Precursors for Astatine Radiopharmaceuticals. Part I: Synthesis